Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
BMC Pediatrics|January 6, 2026
Health-related quality of life, glycaemic control, lifestyle characteristics and SARS-CoV-2 prevalence in children with type 1 diabetes during the COVID-19 pandemic: results of a longitudinal, prospective single-centre Swiss studySerpil Dokhan-Vural, Christian R Kahlert, Caroline Roduit, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 24, 2013
Pimecrolimus, a topical calcineurin inhibitor used in the treatment of atopic eczemaHanna Prucha, Christina Schnopp, Cezmi Akdis, et al.
The Journal of Rheumatology|May 17, 2014
Infliximab in pediatric rheumatology patients: a retrospective analysis of infusion reactions and severe adverse events during 2246 infusions over 12 yearsFlorence A Aeschlimann, Kevin D Hofer, Elvira Cannizzaro Schneider, et al.
Arthritis and Rheumatism|March 13, 2003
Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll-like receptor signalingDiego Kyburz, Janine Rethage, Reinhart Seibl, et al.
Clinical Chemistry and Laboratory Medicine|June 14, 2011
Analytical performance of a multiplexed, bead-based cytokine detection system in small volume samplesMartin Bomert, Gabi Köllisch, Marjut Roponen, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|October 6, 2017
Lung function improvement and airways inflammation reduction in asthmatic children after a rehabilitation program at moderate altitudeEugen Bersuch, Florian Gräf, Ellen D Renner, et al.
Experimental Dermatology|August 13, 2018
The role of environmental factors in allergy: A critical reappraisalStefanie Gilles, Cezmi Akdis, Roger Lauener, et al.
The Journal of Allergy and Clinical Immunology|April 10, 2017
Clinical phenotypes and endophenotypes of atopic dermatitis: Where are we, and where should we go?Thomas Bieber, Angelo M D'Erme, Cezmi A Akdis, et al.
Journal of Inherited Metabolic Disease|October 1, 2010
CRIM-negative infantile Pompe disease: 42-month treatment outcomeMarianne Rohrbach, Andrea Klein, Alice Köhli-Wiesner, et al.
The Journal of Allergy and Clinical Immunology|September 5, 2006
Prenatal initiation of endotoxin airway exposure prevents subsequent allergen-induced sensitization and airway inflammation in miceKerstin Gerhold, Angela Avagyan, Christine Seib, et al.
Pageof 9